Salvatore A. Del Prete, Site 122

Bennett Cancer CenterStamford, Connecticut - 06902 |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS3
- SINCE2009

A Study of Ixabepilone as Second Line Therapy for Locally Advanced Recurrent or Metastatic Endometrial Cancer
August 2009 - June 2013
Endometrial Neoplasms
Paclitaxel
Doxorubicin
Ixabepilone



